
Allegro has announced that hydrocelin, its injectable microparticle hydrogel, showed no signs of toxicity in two preclinical studies. Allegro is …
Biotech firm Adaptimmune has been awarded £2.1 million from the UK government’s Biomedical Catalyst Fund, which was set up to …

The vision for a new UK biomedical research and innovation centre which will be the biggest in Europe has been …
Sanofi-Aventis has formed a strategic alliance with the Centre for Biodmedical Innovation at the Massachusetts Institute of Technology. The alliance, …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

